FDA taps biotech industry veteran as RFK Jr.'s top drug regulator
-
最新报道：FDA veteran Dr. George Tidmarsh emerges as Robert F. Kennedy Jr.'s top choice to lead drug regulation if elected, signaling a potential shift toward alternative medicine oversight. The pediatric immunologist and biotech entrepreneur, known for developing novel therapies for rare diseases, has previously served as an FDA consultant. Tidmarsh's selection reflects Kennedy's campaign focus on reforming pharmaceutical regulations and vaccine policies. The nominee's background includes founding multiple biotech firms and holding faculty positions at Stanford and UCSD medical schools. This move comes as Kennedy positions himself as a challenger to mainstream public health approaches in the 2024 presidential race.
下一篇
Beef Prices Jump 12.4% Year Over Year Amid Supply Shortages
- Beef prices surged 12.4% year-over-year due to supply shortages, driven by reduced cattle ...
24小时热点
热点专题
407297